RUNX3 and cancer: It has been reported that the over expression of Runx3 in gastric cancer cells down regulates Bcl-2 and directly activates the promoter activity of Bim to enhance TGF-β-dependent apoptosis, therefore, sensitizes cancer cells to chemotherapeutic drugs (18, 25).